The Prevalence of Celiac Disease-Specific Auto-Antibodies in Type 1 Diabetes in a Moroccan Population

Table 2

Demographic, clinical, and biological characteristics of the pediatric and adult populations of our series.

Age (Y)

Sex

Height (SD)

Weight (SD)

BMI (SD)

T1D family history

CD family history

HbA1c (%)

Age at T1D onset (Y)

T1D duration (Y)

Daily insulin dose (IU/Kg)

Known microvascular; complications

Known macrovascular; complications

Insulin type prescribed

Insulin regimen

Severe hypoglycemia episodes

Children <15 years (n = 167)

9 ± 3.7

48.5% F

−0.57 ± 1.2

−0.36 ± 1.1

−0.13 ± 1.3

19.2%

4.2%

9.6 ± 2.4

6 ± 3.5

3.1 ± 2.9

0.75 ± 0.2

0%

0%

HI (89%) AN (10.8%)

2 INJ (91.6%) BB (7.8%) 3 INJ (0.6%)

<1/M (93.4%); 1–4/M (6.6%)

Adults ≥15 years (n = 109)

21 ± 6.6

57.8% F

NA

NA

NA

24.8%

5.5%

10.1 ± 2.7

12 ± 7.3

8.8 ± 6.2

0.9 ± 0.3

12.8%

1.8%

HI (77.1%) AN (21.1%)

2 INJ (49.5%) 3 INJ (27.5%) BB (11.9%) FI (11%)

<1/M (95.4%); 1–4/M (1.8%); >1/W (2.8%)

HI: human insulin; AN: analogues; INJ: injections; BB: basal bolus; FI: functional insulin therapy; M: month; W: week; NA: not applicable.